Jun 08, 2021 / 01:45PM GMT
Elaine Quilici -
Hello, again, everyone. If this is your first session of the day, let me reintroduce myself. I'm Elaine Quilici, Senior Editor of Pharmaceutical Executive magazine, and I'm pleased to welcome our next presenter, Catalent's CEO, John Chiminski. John was named Chief Executive Officer of Catalent Pharma Solutions in March 2009. Prior to that, he spent more than 20 years at GE Healthcare, in roles such as President and CEO of Gene Medical Diagnostics, Vice President and General Manager of GE Healthcare's Global Magnetic Resonance Business. And Vice President and General Manager of Global Healthcare Services. Earlier, GE, he held a number of cross-functional leadership positions in both manufacturing and engineering, and we are excited to have John join us today.
But before I hand it over to him, I'd just like to take a minute to ask our audience to post any questions that you might have in the Q&A tab on the right side of your screen, and we will address that at the end of the presentation. So now, I would like to hand it over to John.
John R. Chiminski -
Catalent Inc at CECP Biopharma CEO Investor Forum (Virtual) Transcript
Jun 08, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers